Abstract
Objectives
The goal of this study was to determine childhood clinical predictors of quality of life (QoL) in early adulthood in children with Obsessive-Compulsive Disorder (OCD).
Methods
A longitudinal cohort study was conducted with 36(out of 62 eligible) children with OCD, interviewed once at childhood baseline (mean age: 12.1±2.1, range: 8.0 – 15.8), and again in early adulthood after an average follow-up interval of 9 years. QoL was measured in adulthood with the Longitudinal Interval Follow-up Evaluation Range of Impaired Functioning Tool (LIFE-RIFT).
Results
Forty-two percent of children experienced a remission of OCD symptoms by early adulthood. OCD appeared to most strongly impair the interpersonal relationships and work domains of QoL. QoL and severity of OCD and anxiety symptoms were significantly associated in early adulthood. Primary hoarding symptoms in childhood predicted poor QoL in adulthood. Increased symptoms in the forbidden thoughts dimension in both childhood and adulthood were associated with improved adulthood QoL.
Conclusions
Children for whom OCD symptoms remitted by adulthood showed no evidence of residual impairment in QoL, whereas children whose OCD symptoms failed to remit by adulthood showed at most mild impairment in QoL. Hoarding symptoms in childhood appear to portend not only the persistence of OCD symptoms but also poorer QoL in early adulthood.
Keywords: Obsessive-compulsive disorder, quality of life, LIFE-RIFT, longitudinal study, compulsive hoarding
INTRODUCTION
Obsessive-Compulsive Disorder (OCD) is a psychiatric illness present in 1–3% of both children and adults. OCD is characterized by obsessions – intrusive, unwanted thoughts, images, impulses, and compulsions – stereotyped mental or physical actions that typically reduce anxiety and distress caused by the obsessions [1–3]. OCD significantly diminishes quality of life (QoL) in afflicted children and adults [4; 5]. Indeed, OCD is projected by the World Health Organization to be the 10th most disabling condition in the developed world by the year 2012 [6]. OCD can impair QoL by reducing the quality of social and family relationships, reducing self-esteem, and impairing school and work functioning. Over one-third of adults with OCD are single or struggle in their relationships. Thirty percent of adults with OCD have difficulty working and 62% report OCD-related problems at work. More than 90% of adults with OCD experience low self-esteem [7; 8]. The number of OCD symptoms correlates negatively with QoL in adults with OCD [9]. OCD in adults is associated with a worse QoL than other anxiety disorders, with the exception of post-traumatic stress disorder (PTSD) [8].
By contrast, QoL in pediatric-onset OCD has been sparsely studied. One report indicated that poorer QoL in children with OCD is associated with more severe OCD symptoms, the presence of comorbid internalizing and externalizing symptoms, and female gender [5]. With the introduction of evidence-based treatments for OCD, such as serotonin reuptake inhibitors and cognitive behavioral therapy, a large portion of children with OCD experience a dramatic improvement of their symptoms [10; 11]. A meta-analysis has shown that 40–59% of children with OCD experience a remission of OCD symptoms when followed up at least 1 year later [12]. In this meta-analysis, the persistence of OCD symptoms was associated with earlier age of OCD onset, increased duration of illness prior to treatment, and inpatient hospitalization for OCD. Among the cohort of pediatric OCD patients included in this study, the persistence of OCD symptoms into early adulthood was associated with primary hoarding symptoms and the absence of comorbid tics [13].
During clinical assessments for childhood OCD, families are extremely concerned about prognosis. Many parents’ foremost question is “What will happen to my child?” [12]. This question usually has two components – (1) “Will my child’s OCD get better?” and (2) “Will my child grow up to have a fulfilling life?” Investigators have been most successful at answering the former question – i.e. (1) When combining SSRIs and CBT, there is a better than 50/50 chance that your child’s OCD will remit within 3 months of treatment (compared to a less than 5% chance of remission with no treatment) [11]; (2) over the long-term, most children’s symptoms stay improved and over half of children’s OCD symptoms remain remitted over the long-term [12]. However, we know much less about long-term QoL and how to answer questions like “Will my child have fulfilling family and social relationships as an adult?”, “Will my child be successful at work?”, “Will my child be happy when he grows up?”
Our study looks at adulthood-outcome in terms of QoL in a cohort of children with OCD who were followed into early adulthood. Our goal was to determine childhood predictors and adulthood correlates of QoL in early adulthood in this cohort. We hypothesized that in adulthood, levels of OCD symptom severity and dimensional OCD symptom severity scores, would be associated with current adulthood QoL. We also hypothesized that in children with OCD, (1) primary hoarding symptoms would predict a lower adulthood QoL and (2) that the presence of a comorbid tic disorder in childhood would predict improved QoL.
We hypothesized that primary hoarding symptoms would be associated with poor adulthood quality of life because they have been previously associated with (1) the persistence of pediatric-onset OCD symptoms [14], (2) poor response to pharmacological and behavioral treatments for OCD [15; 16] and (3) increased comorbid emotional difficulties in children [17]. We hypothesized that comorbid tic symptoms would be associated with improved adulthood quality of life because they have been associated previously with the remittance of pediatric-onset OCD symptoms [14]. Tics in OCD patients have been previously associated with a differential response to pharmacological interventions for OCD such as sertraline treatment and antipsychotic augmentation [18; 19].
PATIENTS AND METHODS
Subjects
We conducted a longitudinal follow-up study of adulthood outcomes in pediatric-onset OCD. To participate in the full study, participants were required to: (1) have an OCD diagnosis in childhood; (2) complete an MRI scan and neuropsychological testing studies before reaching the age of 16 and; (3) have reached 16 years of age or older at the time of follow-up. Exclusion criteria included head trauma resulting in loss of consciousness, an IQ lower than 80, past or ongoing substance abuse, and history of seizure. Forty-six out of 62 eligible participants agreed to follow-up interviews. One subject subsequently diagnosed with Asperger’s disorder was dropped from the follow-up sample after his diagnosis was confirmed by physician’s evaluation (MHB) at follow-up. Nine out of the remaining 45 subjects who participated in follow-up interview did not complete follow-up quality of life ratings. These were subjects who withdrew from the follow-up interview after initially agreeing typically due to the length of time of the follow-up assessment (3 hours).
Childhood baseline interview occurred at an average age of 12.1±2.1 (range: 8.0 – 15.8) years. Follow-up interviews occurred at an average age of 21.1±3.1 (range 16.0 – 27.0) years. The average interval between the baseline and follow-up interviews was 9±2.9 years. QoL information was not available on 8 additional individuals from the original cohort. Informed consent was attained from parents and participants at the time of the childhood baseline assessment and at follow-up. Please refer to Table 1 for baseline demographic information on participants and non-participants in this study.
Table 1. Subject Demographics.
Demographic | Participants | Remitted | Non-Remitted | Non-Participants |
---|---|---|---|---|
N | 36 | 15 | 21 | 16 |
Age | 12.1 +/− 2.0 | 12.2 +/− 2.2 | 12.1 +/− 1.9 | 9.9 +/− 1.6 |
Gender (% male) | 78% | 93% | 67% | 75% |
OCD Severity at Childhood MRI | 10.8 +/− 7.3 | 8.0 +/− 5.0 | 13.0 +/− 8.3 | 14.2 +/− 9.8 |
Tics | 53% | 31% | 79% | 69% |
ADHD | 53% | 47% | 57% | 38% |
Primary Hoarding | 25% | 7% | 38% | 6% |
Medication Use in Childhood | ||||
SRI | 94% | 100% | 90% | 56% |
Neuroleptics | 50% | 56% | 43% | 31% |
Alpha-2 Agonists | 28% | 27% | 29% | 6% |
Medication Use in Adulthood | ||||
SRI | 61% | 60% | 62% | |
Neuroleptics | 14% | 19% | 10% | |
Alpha-2 Agonists | 3% | 0% | 5% |
Baseline Assessment in Childhood
Baseline assessment was conducted when children were less than 16 years of age. The procedures of our baseline assessment have been described previously in more detail [13]. A structured diagnostic interview was conducted with the Schedule for Tourette and Other Behavioral Syndromes and clinical diagnoses established by two psychiatrists utilizing a best-estimate consensus procedure following a review of all available materials [20; 21]. Diagnoses classified participants based on the presence or absence of the following conditions: Chronic Tic Disorder (CTD), Major Depressive Disorder (depression), Oppositional Defiant Disorder (ODD), Tourette’s Syndrome (TS), comorbid anxiety disorder besides OCD (anxiety), and Attention-Deficit Hyperactivity Disorder (ADHD). Current and worst-ever severities of OCD and tic symptoms were rated using the Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS) and Yale Global Tic Severity Scale (YGTSS), respectively [22; 23]. Severity of comorbid depressive symptoms was measured with the Children’s Depression Rating Scale (CDRS) [24].. Finally, a detailed interview concerning medication history, family history, age of onset of OCD, and tic symptoms was also conducted at baseline.
Based on data in collected in childhood (baseline clinical assessment, CY-BOCS symptom checklist and symptom dimensional factor scores (see [25] for further details), individuals were classified into four mutually exclusive primary symptom dimensions (cleaning, forbidden thoughts, symmetry and hoarding) by a rater blinded to adulthood outcome. Primary symptom dimension was defined as the OCD symptoms causing the greatest distress and impairment in global functioning.
Follow-Up Assessment in Adulthood
During the early adulthood follow-up assessment, current and worst-ever ratings of OCD and tic severity were determined using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and YGTSS [22; 23]. Dimensional symptoms of OCD were evaluated using the Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS) [26]. The Structured Clinical Interview for DSM-IV Axis I Disorder was used to screen for comorbid psychiatric conditions. QoL was measured IN adulthood with the Longitudinal Interval Follow-up Evaluation Range of Impaired Functioning Tool (LIFE-RIFT) [27]. The LIFE-RIFT is a semi-structured, clinician-rated measure of functional impairment. The LIFE-RIFT has a total score comprised of individual domain scores for the following areas of functioning: household duties, work, recreation, relationships with family, relationships with friends, schoolwork, and global life satisfaction (this item is patient-rated). Scores in each domain range from 1 to 5, with higher scores indicating worse functioning. A detailed medication, family, and medical history was taken during the follow-up interview. When possible, a family member or co-habitating adult was interviewed to augment the subjects’ interviews.
DATA ANALYSIS
All statistical analyses were performed in SPSS version 16.0. Persons with remitted OCD (“remitters”) were compared to adults whose OCD did not remit (“non-remitters”) on QoL measures using a Student’s t-test. A Y-BOCS score of <8 was chosen as our criteria for remission because the anchor point of 8 demarcates subclinical (YBOCS 0–7) from clinical OCD symptoms (YBOCS≥8) [28]. Our a priori hypothesis was that non-remitters would have higher LIFE-RIFT scores (indicating a greater impairment in functioning) than remitters. In exploratory analyses, each of the 4 subdomains of the LIFE-RIFT were compared between the two groups. A statistical threshold of p<0.05 was used for all t-tests. The analysis regarding the LIFE-RIFT subdomains should be considered exploratory and used for hypothesis generating purposes only.
Linear regression was performed to determine (1) clinical characteristics in early adulthood associated with concurrent QoL and (2) childhood baseline characteristics that predict future QoL. For all linear regression analyses, the primary outcome and dependent variable was total LIFE-RIFT score. Before linear regression was performed a histogram of LIFE-RIFT score at adulthood follow-up was inspected for normality.
For the investigation of concurrent adulthood clinical characteristics associated with QoL at the time of follow-up, gender and age at follow-up assessment were added as covariates. Our two a priori hypotheses in this analysis were that adulthood measures of OCD symptom severity and OCD symptom dimension scores on the DY-BOCS would correlate with adulthood measures of QoL. Current Y-BOCS severity was added as an additional covariate in our hypothesis testing of the correlation of OCD symptom dimension severity scores on the DY-BOCS. The dimensional severity scores from the aggression and sexual/religious dimensions of the DY-BOCS were combined a priori based on recent evidence that these two symptom clusters form a single OCD symptom dimension [29]. The statistical threshold for significance was set at p<0.025 using a strict Bonferroni correction to account for our two a priori hypotheses. In exploratory analyses, we additionally conducted a forward stepwise linear regression model to determine the best-fitting model of adulthood variables associated with concurrent QoL. The criteria for entry into the model was p<.05 and exit was p>0.1. The variables included in this model were current OCD severity (Y-BOCS), current depression symptom severity (Hamilton Depression Rating Scale), current anxiety symptom severity (Hamilton Anxiety Rating Scale), symptom dimension scores on the DY-BOCS, current tic symptom severity (YGTSS), number of comorbid anxiety disorders and presence of comorbid substance use disorder at follow-up. Most adulthood clinical variables with the exception of gender, presence of substance use disorder and number of anxiety disorders were highly intercorrelated. We decided to include all of them despite significant intercorrelation because we felt they represented clinically important variables. We additionally used forward stepwise regression as our method of analysis to limit the effect of these intercorrelations on our final analysis. Specific intercorrelations between our exploratory variables are available as supplementary material upon request. Significant exploratory findings should be used only for hypothesis generation and not to provide conclusive confirmatory findings.
In assessing which baseline clinical characteristics in childhood predict QoL in early adulthood, we included as covariates age at baseline, age at follow-up and gender. Our three a priori hypotheses were that (1) presence of hoarding symptoms, (2) absence of comorbid tics and (3) childhood severity of OCD symptoms would predict QoL in adulthood. These hypotheses were suggested by their association with persistence of OCD symptoms in this same cohort. Our statistical threshold for significance was set at p<0.018 using a strict Bonferroni correction to account for our three a priori hypotheses. In exploratory analyses, we additionally conducted a forward stepwise linear regression model to determine the best-fitting model of childhood variables predicting adulthood QoL. The criteria for entry into the model was p<.05 and exit was p>0.1. The variables included in this model were worst-ever OCD severity, worst-ever tic severity, current depression severity (CDRS), age of onset, presence of tic symptoms, presence of ADHD, ODD, depression or anxiety disorder, factor scores on each of the 4 primary symptom dimensions (forbidden thoughts, symmetry, cleaning and hoarding). There were few significant correlations between childhood clinical variables with the exception of (1) tics and worst-ever YGTSS score, (2) primary hoarding symptoms and hoarding factor score and (3) comorbid ADHD and ODD diagnoses. We decided to include all of them despite significant intercorrelation because we felt they represented clinically important variables. Intercorrelations between exploratory variables is available as supplementary material upon request. Significant exploratory findings should be used only for hypothesis generation and not to provide conclusive confirmatory findings.
RESULTS
Subjects
Participants were 12.1 ± 2.0 (range 8.0 – 15.8) years at baseline childhood assessment. The follow-up assessment in adulthood occurred after an average duration of 9.0 ± 2.0 years. The average age at early adulthood interviews was 21.1 ± 3.1 (range 16.0 – 27.0) years. We re-interviewed 36 out of 61 eligible participants at adulthood follow-up. At the time of the adulthood follow-up assessment, OCD had remitted in 15 participants’ (42%) OCD (Y-BOCS<8); 14 (39%) had minimal OCD (YBOCS: 8–15); 5 (14%) had moderate OCD (Y-BOCS: 16–23); and 2 (6%) had severe OCD (YBOCS>23). Table 1 describes the demographic characteristics of participants and non-participants in the current study. Medication use is also described in Table 1.
Based on data at childhood assessment, 9 participants (1 remitted, 8 non-remitted) had primary hoarding symptoms, 11 participants with primary symptoms in the forbidden thoughts dimension (5 remitted, 6 non-remitted), 10 participants with primary symptoms in the symmetry dimension (6 remitted, 4 non-remitted) and 6 participants with primary symptoms in the cleaning dimension (3 remitted, 3 non-remitted).
Remitters vs. Non-Remitters
Remitters demonstrated significantly better QoL than non-remitters, particularly in the LIFE-RIFT domains of interpersonal relationships and work. Comparison of remitters to non-remitters on overall QoL and LIFE-RIFT domain scores is depicted in Table 2.
Table 2.
Remitters (N = 21) | Non-Remitters (N = 16) | |
---|---|---|
LIFE-RIFT* | 6.5 ± 1.6 | 8.8 ± 3.5 |
Work** | 1.4 ± 0.7 | 2.4 ± 1.6 |
Interpersonal Relations* | 1.9 ± 0.7 | 2.6 ± 1.3 |
Satisfaction | 1.7 ± 0.6 | 2.1 ± 1.0 |
Recreation | 1.5 ± 0.5 | 1.7 ± 1.0 |
=p<0.05;
=P<0.01 Higher scores on the LIFE-RIFT indicate worse functioning.
Clinical Correlates of QoL in Adulthood
In accordance with our a priori hypotheses, OCD severity in early adulthood was associated with QoL in adulthood (β = 0.168, SE = 0.041, p<0.001; F(3,32)=5.4, p=0.004, R2=0.34). For analyses of OCD symptom dimensions (while controlling for overall OCD severity), more symptoms in the Forbidden Thoughts dimension (combined aggression, sexual, and religious items on the DY-BOCS) were associated with an improved QoL in adulthood (β = −0.158, SE = 0.075, p=0.045; F(4,31)=5.3, p=0.003, R2=0.43) for a given degree of overall OCD severity.
In our best-fitting exploratory model (F(3,32)=9.8, p<0.001, R2=0.53), the overall severity of current OCD (β=0.185, SE=0.050, p = 0.001) and anxiety symptoms (β=0.195, SE=0.074, p = 0.014) as well as the severity of forbidden thoughts symptoms on the DY-BOCS (β=−0.268, SE=0.080, p = 0.003) were included in the model. Decreased OCD and anxiety symptom severity and increased symptomatology in the forbidden thoughts dimension were associated with improved QoL.
Childhood Predictors of QoL in Adulthood
In accordance with our a priori hypotheses, primary hoarding OCD symptoms in childhood (β=2.370, SE=0.884, p = 0.01; F(4,31)=2.8, p=0.04, R2=0.27) predicted poorer QoL in early adulthood. By contrast, OCD severity in childhood (β=0.015, SE=0.0.059, p = 0.80; F(4,31)=1.2, p=NS) and the presence of a comorbid tic disorder in childhood (β=0.140, SE=0.808, p = 0.86; F(4,31)=1.0, p=NS) were not associated with QoL in adulthood.
In our best-fitting exploratory model (F(2,33)=6.8, p<0.01, R2=0.38), only the presence of primary hoarding symptoms in childhood (β=3.331, SE=1.048, p = 0.004) and factor score on the forbidden thoughts dimension (β=−2.996, SE=1.159, p = 0.02) were included in the model. The presence of hoarding symptoms and lower scores on the forbidden thoughts dimension were associated with poor adulthood QoL.
DISCUSSION
OCD remitted in 42% of the children who were followed into their early adulthood. An even greater percentage (57%) showed no evidence of impairment in QoL in adulthood. The severity of OCD symptoms in adulthood correlated strongly with overall QoL. Those children whose OCD symptoms remitted by adulthood showed no evidence of residual impairment in QoL. OCD remitters had average LIFE-RIFT domain scores of less than 2 in all domains, (interpersonal relationships, work, satisfaction and recreation) indicating no evidence of impairment. More than half (57%) of non-remitters had some evidence of impairment in one or more of the LIFE-RIFT domains (score greater than or equal to 2) compared with 25% of remitters. Non-remitters had a mean LIFE-RIFT score of 8.8, indicating mild impairment in QoL similar to or slightly less impaired than previous cohorts of adults who recently recovered from depression or anxiety disorders [27]. The QoL ratings in our non-remitted children show much less impairment compared to previous adult samples with other active psychiatric illnesses [27]. This result is important but not surprising since few individuals were still receiving active psychiatric treatment. These findings should provide hope to families of children with OCD because they suggest fairly good adulthood QoL even if OCD symptoms do not remit completely. Non-remitters were most impaired in interpersonal relationships and work functioning, although the average impairment in these domains was still in the mild range.
Consistent with our a priori hypotheses, primary hoarding OCD symptoms in childhood predicted poorer QoL in adulthood. Past studies have demonstrated worse treatment response with cognitive-behavioral therapy and pharmacotherapy in OCD patients with hoarding symptoms [30; 15; 31–36; 13]. Previous analysis in this cohort has also demonstrated that primary hoarding symptoms in childhood were associated with a persistence of OCD symptoms into adulthood [13]. Our cohort of children was unusual in having a high proportion of subjects with primary hoarding symptoms (24%) compared to other childhood OCD studies [37–39; 17]. This high proportion of hoarding subjects gave us increased power to find clinical differences in subjects with primary hoarding symptoms.
In both child and adults increased symptomatology in the forbidden thoughts dimension was associated with improved adulthood QoL. The forbidden thoughts dimension includes obsessions involving sexual and religious themes as well as obsessions involving fear of harm coming to self or others and violent and horrific images [29]. Certain checking compulsions are also often associated with the forbidden thoughts dimension [29]. Consistent with this finding previous research has associated these symptoms with improved long-term outcome in adults with OCD [40]. Additionally, some studies have suggested that individuals with symptoms in this dimension may be more responsive to SRI pharmacotherapy [41; 42]
By contrast, no other childhood clinical characteristics predicted QoL in adulthood. Thus, childhood comorbid illnesses such as tic disorders, ADHD, depression and other anxiety disorders had no significant value for predicting QoL in early adulthood.
In light of these findings, it is important to take note of our study’s limitations. First, QoL is a subjective measure that is intrinsically difficult to quantify and compare among individuals. Second, the LIFE-RIFT was only administered during the assessment in adulthood and analyzed in the absence of LIFE-RIFT data on healthy controls. Third, our sample represents a clinically referred population who were likely more severely ill but also more expertly treated than pediatric OCD patients in the general population. These factors make our results generalizable to patients in OCD specialty clinics, but less generalizable to community samples. Fourth, average LIFE-RIFT scores indicated low levels of impairment for both remitters and non-remitters. These low scores limited our statistical power to detect childhood predictors and adulthood correlates of quality of life. Finally, the participants in our cohort commonly received medications and/or behavioral therapy for OCD throughout the study interval; our study therefore reports on the clinical course of OCD with treatment rather than on the natural history of the untreated disorder.
Our cohort of children with OCD followed to early adulthood showed modest impairment of QoL on average. QoL in adulthood was correlated strongly with residual OCD symptom severity in adulthood, but not with OCD symptom severity in childhood. Primary hoarding symptoms in childhood predicted persistence of OCD symptoms in adulthood and poorer QoL in adulthood in our study. Continued research into developing better behavioral and pharmacological treatment for individuals with compulsive hoarding symptoms is needed, as are controlled, longitudinal studies examining QoL in pediatric OCD.
Supplementary Material
Acknowledgements
The authors acknowledge the National Institute of Mental Health support of the Yale Child Study Center Research Training Program (MHB, JFL), K05MH076273 (JFL), K02MH074677 (BSP), R01MH068318 (BSP), the National Institutes of Health Loan Repayment Program (MHB), the support of the Tourette’s Syndrome Association Inc. (JFL, MHB), the APIRE/Eli Lilly Psychiatric Research Fellowship (MHB), the AACAP/ Eli Lilly Pilot Research Award (MHB), the Trichotillomania Learning Center Research Award (MHB), NARSAD Young Investigator Award (MHB) and the APA/NIMH PMRTP Program (ALW).
Footnotes
Disclosures: the authors have no conflicts of interest to disclose.
REFERENCES
- 1.Karno M, Golding JM, Sorenson SB, Burnam MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry. 1988;45:1094–1099. doi: 10.1001/archpsyc.1988.01800360042006. [DOI] [PubMed] [Google Scholar]
- 2.Valleni-Basile LA, Garrison CZ, Jackson KL, Waller JL, McKeown RE, Addy CL, Cuffe SP. Frequency of obsessive-compulsive disorder in a community sample of young adolescents. J Am Acad Child Adolesc Psychiatry. 1994;33:782–791. doi: 10.1097/00004583-199407000-00002. [DOI] [PubMed] [Google Scholar]
- 3.Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602. doi: 10.1001/archpsyc.62.6.593. [DOI] [PubMed] [Google Scholar]
- 4.Freeman JB, Choate-Summers ML, Moore PS, Garcia AM, Sapyta JJ, Leonard HL, Franklin ME. Cognitive behavioral treatment for young children with obsessive-compulsive disorder. Biol Psychiatry. 2007;61:337–343. doi: 10.1016/j.biopsych.2006.12.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lack CW, Storch EA, Keeley ML, Geffken GR, Ricketts ED, Murphy TK, Goodman WK. Quality of life in children and adolescents with obsessive-compulsive disorder: base rates, parent-child agreement, and clinical correlates. Soc Psychiatry Psychiatr Epidemiol. 2009 doi: 10.1007/s00127-009-0013-9. [DOI] [PubMed] [Google Scholar]
- 6.Murray C, Lopez A, editors. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard University Press; 1996. [Google Scholar]
- 7.Koran LM. Quality of life in obsessive-compulsive disorder. Psychiatr Clin North Am. 2000;23:509–517. doi: 10.1016/s0193-953x(05)70177-5. [DOI] [PubMed] [Google Scholar]
- 8.Moritz S. A review on quality of life and depression in obsessive-compulsive disorder. CNS Spectr. 2008;13:16–22. doi: 10.1017/s1092852900026894. [DOI] [PubMed] [Google Scholar]
- 9.Moritz S, Rufer M, Fricke S, Karow A, Morfeld M, Jelinek L, Jacobsen D. Quality of life in obsessive-compulsive disorder before and after treatment. Compr Psychiatry. 2005;46:453–459. doi: 10.1016/j.comppsych.2005.04.002. [DOI] [PubMed] [Google Scholar]
- 10.King R, et al. Practice Parameters for the Assessment and Treatment of Children and Adolescents With Obsessive-Compulsive Disorder. American Academy of Child and Adolescent Psychiatry (AACAP) 1998 doi: 10.1097/00004583-199810001-00003. [DOI] [PubMed] [Google Scholar]
- 11.Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA. 2004;292:1969–1976. doi: 10.1001/jama.292.16.1969. [DOI] [PubMed] [Google Scholar]
- 12.Stewart S, Geller D, Jenike M, Pauls D, Shaw D, Mullin B, Faraone S. Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiatr Scand. 2004;110:4–13. doi: 10.1111/j.1600-0447.2004.00302.x. [DOI] [PubMed] [Google Scholar]
- 13.Bloch M, Craiglow B, Landeros-Weisenberger A, Dombrowski P, Panza K, Peterson B, Leckman J. Predictors of Early Adult Outcome in Pediatric-Onset Obsessive-Compulsive Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 2008 doi: 10.1542/peds.2009-0015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Bloch MH, Craiglow BG, Landeros-Weisenberger A, Dombrowski PA, Panza KE, Peterson BS, Leckman JF. Predictors of early adult outcomes in pediatric-onset obsessive-compulsive disorder. Pediatrics. 2009;124:1085–1093. doi: 10.1542/peds.2009-0015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 1999;156:1409–1416. doi: 10.1176/ajp.156.9.1409. [DOI] [PubMed] [Google Scholar]
- 16.Mataix-Cols D, Marks IM, Greist JH, Kobak KA, Baer L. Obsessive-compulsive symptom dimensions as predictors of compliance with and response to behaviour therapy: results from a controlled trial. Psychother Psychosom. 2002;71:255–262. doi: 10.1159/000064812. [DOI] [PubMed] [Google Scholar]
- 17.Mataix-Cols D, Nakatani E, Micali N, Heyman I. Structure of obsessive-compulsive symptoms in pediatric OCD. J Am Acad Child Adolesc Psychiatry. 2008;47:773–778. doi: 10.1097/CHI.0b013e31816b73c0. [DOI] [PubMed] [Google Scholar]
- 18.Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry. 2006;11:622–632. doi: 10.1038/sj.mp.4001823. [DOI] [PubMed] [Google Scholar]
- 19.March JS, Franklin ME, Leonard H, Garcia A, Moore P, Freeman J, Foa E. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry. 2007;61:344–347. doi: 10.1016/j.biopsych.2006.09.035. [DOI] [PubMed] [Google Scholar]
- 20.Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM. Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry. 1982;39:879–883. doi: 10.1001/archpsyc.1982.04290080001001. [DOI] [PubMed] [Google Scholar]
- 21.Pauls DL, Alsobrook JP, 2nd, Goodman W, Rasmussen S, Leckman JF. A family study of obsessive-compulsive disorder. Am J Psychiatry. 1995;152:76–84. doi: 10.1176/ajp.152.1.76. [DOI] [PubMed] [Google Scholar]
- 22.Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989;28:566–573. doi: 10.1097/00004583-198907000-00015. [DOI] [PubMed] [Google Scholar]
- 23.Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, Cicchetti D, Leckman JF. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997;36:844–852. doi: 10.1097/00004583-199706000-00023. [DOI] [PubMed] [Google Scholar]
- 24.Poznanski EO, Cook SC, Carroll BJ. A depression rating scale for children. Pediatrics. 1979;64:442–450. [PubMed] [Google Scholar]
- 25.Leckman JF, Grice DE, Boardman J, Zhang H, Vitale A, Bondi C, Alsobrook J, Peterson BS, Cohen DJ, Rasmussen SA, Goodman WK, McDougle CJ, Pauls DL. Symptoms of obsessive-compulsive disorder. Am J Psychiatry. 1997;154:911–917. doi: 10.1176/ajp.154.7.911. [DOI] [PubMed] [Google Scholar]
- 26.Rosario-Campos MC, Miguel EC, Quatrano S, Chacon P, Ferrao Y, Findley D, Katsovich L, Scahill L, King RA, Woody SR, Tolin D, Hollander E, Kano Y, Leckman JF. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions. Mol Psychiatry. 2006;11:495–504. doi: 10.1038/sj.mp.4001798. [DOI] [PubMed] [Google Scholar]
- 27.Leon AC, Solomon DA, Mueller TI, Turvey CL, Endicott J, Keller MB. The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment. Psychol Med. 1999;29:869–878. doi: 10.1017/s0033291799008570. [DOI] [PubMed] [Google Scholar]
- 28.Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989;46:1006–1011. doi: 10.1001/archpsyc.1989.01810110048007. [DOI] [PubMed] [Google Scholar]
- 29.Bloch MH, Landeros-Weisenberger A, Rosario MC, Pittenger C, Leckman JF. Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am J Psychiatry. 2008;165:1532–1542. doi: 10.1176/appi.ajp.2008.08020320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Abramowitz JS. Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review. J Consult Clin Psychol. 1997;65:44–52. doi: 10.1037//0022-006x.65.1.44. [DOI] [PubMed] [Google Scholar]
- 31.Saxena S, Maidment KM, Vapnik T, Golden G, Rishwain T, Rosen RM, Tarlow G, Bystritsky A. Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment. J Clin Psychiatry. 2002;63:21–27. [PubMed] [Google Scholar]
- 32.Masi G, Millepiedi S, Mucci M, Bertini N, Milantoni L, Arcangeli F. A naturalistic study of referred children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2005;44:673–681. doi: 10.1097/01.chi.0000161648.82775.ee. [DOI] [PubMed] [Google Scholar]
- 33.Mataix-Cols D, Rosario-Campos MC, Leckman JF. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry. 2005;162:228–238. doi: 10.1176/appi.ajp.162.2.228. [DOI] [PubMed] [Google Scholar]
- 34.Rufer M, Fricke S, Moritz S, Kloss M, Hand I. Symptom dimensions in obsessive-compulsive disorder: prediction of cognitive-behavior therapy outcome. Acta Psychiatr Scand. 2006;113:440–446. doi: 10.1111/j.1600-0447.2005.00682.x. [DOI] [PubMed] [Google Scholar]
- 35.Saxena S, Brody AL, Maidment KM, Baxter LR., Jr Paroxetine treatment of compulsive hoarding. J Psychiatr Res. 2007;41:481–487. doi: 10.1016/j.jpsychires.2006.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Stein DJ, Andersen EW, Overo KF. Response of symptom dimensions in obsessive-compulsive disorder to treatment with citalopram or placebo. Rev Bras Psiquiatr. 2007;29:303–307. doi: 10.1590/s1516-44462007000400003. [DOI] [PubMed] [Google Scholar]
- 37.Delorme R, Bille A, Betancur C, Mathieu F, Chabane N, Mouren-Simeoni MC, Leboyer M. Exploratory analysis of obsessive compulsive symptom dimensions in children and adolescents: a prospective follow-up study. BMC Psychiatry. 2006;6:1. doi: 10.1186/1471-244X-6-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.McKay D, Piacentini J, Greisberg S, Graae F, Jaffer M, Miller J. The structure of childhood obsessions and compulsions: dimensions in an outpatient sample. Behav Res Ther. 2006;44:137–146. doi: 10.1016/j.brat.2005.02.001. [DOI] [PubMed] [Google Scholar]
- 39.Stewart SE, Rosario MC, Brown TA, Carter AS, Leckman JF, Sukhodolsky D, Katsovitch L, King R, Geller D, Pauls DL. Principal components analysis of obsessive-compulsive disorder symptoms in children and adolescents. Biol Psychiatry. 2007;61:285–291. doi: 10.1016/j.biopsych.2006.08.040. [DOI] [PubMed] [Google Scholar]
- 40.Eisen JL, Greenberg BD, Mancebo M, Pinto A, Rasmussen S, Marsland R, Orphanides A, Dyck I, Stout R. OCD Subtypes. Toronto, CA: American Psychiatric Association; 2006. [Google Scholar]
- 41.Nestadt G, Samuels J, Riddle M, Bienvenu OJ, 3rd, Liang KY, LaBuda M, Walkup J, Grados M, Hoehn-Saric R. A family study of obsessive-compulsive disorder. Arch Gen Psychiatry. 2000;57:358–363. doi: 10.1001/archpsyc.57.4.358. [DOI] [PubMed] [Google Scholar]
- 42.Landeros-Weisenberger A, Bloch MH, Kelmendi B, Wegner R, Nudel J, Dombrowski P, Pittenger C, Krystal JH, Goodman WK, Leckman JF, Coric V. Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder. J Affect Disord. 2009 doi: 10.1016/j.jad.2009.06.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.